• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV 0.26% $15.66

CLINUVEL PHARMACEUTICALS LIMITED - Corporate Spotlight

Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical... Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No Corporate Spotlight currently available.

(20min delay)
Last
$15.66
Change
0.040(0.26%)
Mkt cap ! $798.1M
Open High Low Value Volume
$15.68 $15.98 $15.61 $956.3K 60.62K

Buyers (Bids)

No. Vol. Price($)
7 296 $15.66
 

Sellers (Offers)

Price($) Vol. No.
$15.69 81 9
View Market Depth
Last trade - 12.48pm 28/05/2024 (20 minute delay) ?
Last
$15.77
  Change
0.040 ( 0.78 %)
Open High Low Volume
$15.68 $15.97 $15.61 2715
Last updated 13.08pm 28/05/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.